Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Nov 29;19(12):1568-1569.
doi: 10.1093/neuonc/nox164.

IDH mutation testing in gliomas-where do we draw the line?

Farshad Nassiri  1 , Gelareh Zadeh  1 , Kenneth Aldape  1
Affiliations
Comment

IDH mutation testing in gliomas-where do we draw the line?

Farshad Nassiri et al. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Louis DN, Perry A, Reifenberger G et al. . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
    1. Sanson M, Marie Y, Paris S et al. . Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol. 2009;27(25):4150–4154. - PubMed
    1. Ceccarelli M, Barthel FP, Malta TM et al. ; TCGA Research Network Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell. 2016;164(3):550–563. - PMC - PubMed
    1. Brat DJ, Verhaak RGW et al. ; Cancer Genome Atlas Research Network Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372(26):2481–2498. - PMC - PubMed
    1. DeWitt JC, Jordan JT, Frosch MP et al. . Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations. Neuro Oncol 2017; 19(12):1640–1650. - PMC - PubMed

Substances